Aditxt, Inc. Signs Material Definitive Agreement
Ticker: ADTX · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1726711
Sentiment: neutral
Topics: material-agreement, filing-update
TL;DR
Aditxt signs new deal, filing includes financials.
AI Summary
On April 10, 2025, Aditxt, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates a significant new contract or partnership for Aditxt, Inc., which could impact its future revenue and strategic direction.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new opportunities but also potential risks and obligations for the company.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- April 10, 2025 (date) — Date of earliest event reported
- Aditx Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Aditxt, Inc. on April 10, 2025?
The filing states that Aditxt, Inc. entered into a material definitive agreement on April 10, 2025, but the specific details of the agreement are not provided in the excerpt.
What other information is included in this 8-K filing besides the material definitive agreement?
This 8-K filing also includes financial statements and exhibits related to the material definitive agreement.
When was Aditxt, Inc. formerly known as Aditx Therapeutics, Inc.?
The filing indicates that Aditxt, Inc. was formerly known as Aditx Therapeutics, Inc. with a date of name change in 20201113.
What is the principal executive office address for Aditxt, Inc.?
The principal executive offices of Aditxt, Inc. are located at 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.
What is the Standard Industrial Classification code for Aditxt, Inc.?
Aditxt, Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Aditxt, Inc. (ADTX).